Optimizing Visual And Refractive Outcomes: Toric Iol Implantation In Combined Cataract And Vitreomacular Interface Surgery"
Published 2025 - 43rd Congress of the ESCRS
Reference: PO899 | Type: Poster | DOI: 10.82333/wpsr-4246
Authors: Pavel Beliakouski* 1 , Mikalai Pazniak 1 , Aleh Pazniak 1 , Dmitriy Abelskyi 1 , Elena Likhorad 1 , Kirill Zhukov 1 , Yury Belkevich 1 , Wladimir Kotovich 1
1Ophthalmology,Eye Microsurgery Center “Voka”,Minsk,Belarus
Purpose
To analyze the effectiveness of refractive lensectomy with implantation of Clareon Toric IOL (Alcon) in patients undergoing simultaneous surgery for vitreomacular interface pathology.
Setting
To evaluate visual and refractive outcomes in patients undergoing refractive lensectomy with Clareon Toric (Alcon) implantation for concurrent epiretinal membrane surgery, lamellar macular hole, and vitreomacular traction syndrome.
Methods
A total of 34 patients (34 eyes) underwent refractive lensectomy due to early peripheral cataract, ametropia, and astigmatism, followed by implantation of Clareon Toric IOL (Alcon, USA) in combination with surgery for vitreomacular interface pathology. The mean patient age was 66.42 ± 7.28 years. Preoperative parameters included UCVA of 0.19 ± 0.13, BCVA of 0.5 ± 0.2, sph refraction of -0.40 ± 1.85 D, cyl refraction of -1.16 ± 1.36 D, corneal ast of -1.52 ± 0.76 D, axial length of 24.36 ± 1.55 mm, and maximum retinal thickness of 426.94 ± 72.42 μm. IOL positioning was planned using the Barrett Online Calculator.
Results
Three months postoperatively, UCVA significantly improved to 0.7 ± 0.24 (p < 0.005), exceeding preoperative BCVA, which also improved to 0.79 ± 0.16 (p < 0.005). Spherical refraction shifted toward emmetropia (0.08 ± 0.57 D, p < 0.005), and cylindrical refraction decreased (-0.4 ± 0.52 D, p < 0.005). Maximum retinal thickness reduced to 306.29 ± 72.42 μm (p < 0.005).
Conclusions
Implantation of Clareon Toric IOL (Alcon, USA) in patients undergoing combined cataract and vitreomacular interface pathology surgery provides predictable refractive outcomes and significant visual function improvement. Stable IOL positioning was confirmed by reduced residual astigmatism. Astigmatism correction in combined surgery enhances patients’ quality of life and reduces dependence on spectacle correction.